This title appears in the Scientific Report :
2015
Please use the identifier:
http://dx.doi.org/10.1016/j.coph.2014.10.008 in citations.
Excitatory amino acid transporters: recent insights into molecular mechanisms, novel modes of modulation and new therapeutic possibilities.
Excitatory amino acid transporters: recent insights into molecular mechanisms, novel modes of modulation and new therapeutic possibilities.
The five excitatory amino acid transporters (EAAT1-5) mediating the synaptic uptake of the major excitatory neurotransmitter glutamate are differently expressed throughout the CNS and at the synaptic level. Although EAATs are crucial for normal excitatory neurotransmission, explorations into the phy...
Saved in:
Personal Name(s): | Jensen, Anders A (Corresponding Author) |
---|---|
Fahlke, Christoph / Bjørn-Yoshimoto, Walden E / Bunch, Lennart | |
Contributing Institute: |
Zelluläre Biophysik; ICS-4 |
Published in: | Current opinion in pharmacology, 20 (2015) S. 116–123 |
Imprint: |
Amsterdam [u.a.]
Elsevier Science
2015
|
PubMed ID: |
25466154 |
DOI: |
10.1016/j.coph.2014.10.008 |
Document Type: |
Journal Article |
Research Program: |
Physical Basis of Diseases |
Publikationsportal JuSER |
LEADER | 04322nam a2200673 a 4500 | ||
---|---|---|---|
001 | 173233 | ||
005 | 20210129214608.0 | ||
024 | 7 | |a 10.1016/j.coph.2014.10.008 |2 doi | |
024 | 7 | |a pmid:25466154 |2 pmid | |
024 | 7 | |a 1471-4892 |2 ISSN | |
024 | 7 | |a 1471-4973 |2 ISSN | |
024 | 7 | |a WOS:000349738600018 |2 WOS | |
024 | 7 | |a altmetric:2862751 |2 altmetric | |
037 | |a FZJ-2014-06644 | ||
041 | |a English | ||
082 | |a 340 | ||
100 | 1 | |a Jensen, Anders A |0 P:(DE-HGF)0 |b 0 |e Corresponding Author | |
245 | |a Excitatory amino acid transporters: recent insights into molecular mechanisms, novel modes of modulation and new therapeutic possibilities. | ||
260 | |a Amsterdam [u.a.] |c 2015 |b Elsevier Science | ||
520 | |a The five excitatory amino acid transporters (EAAT1-5) mediating the synaptic uptake of the major excitatory neurotransmitter glutamate are differently expressed throughout the CNS and at the synaptic level. Although EAATs are crucial for normal excitatory neurotransmission, explorations into the physiological functions mediated by the different transporter subtypes and their respective therapeutic potential have so far been sparse, in no small part due to the limited selection of pharmacological tools available. In the present update, we outline important new insights into the molecular compositions of EAATs and their intricate transport process, the novel approaches to pharmacological modulation of the transporters that have emerged, and interesting new perspectives in EAAT as drug targets proposed in recent years. | ||
588 | |a Dataset connected to CrossRef, juser.fz-juelich.de, PubMed, | ||
700 | 1 | |a Fahlke, Christoph |0 P:(DE-Juel1)136837 |b 1 |u fzj | |
700 | 1 | |a Bjørn-Yoshimoto, Walden E |0 P:(DE-HGF)0 |b 2 | |
700 | 1 | |a Bunch, Lennart |0 P:(DE-HGF)0 |b 3 | |
773 | |a 10.1016/j.coph.2014.10.008 |g p. S1471489214001362 |0 PERI:(DE-600)2038524-9 |p 116–123 |t Current opinion in pharmacology |v 20 |y 2015 |x 1471-4892 | ||
856 | 4 | |u http://juser.fz-juelich.de/record/173233/files/FZJ-2014-06644.pdf |y Restricted | |
909 | C | O | |o oai:juser.fz-juelich.de:173233 |p VDB |
910 | 1 | |a Forschungszentrum Jülich GmbH |0 I:(DE-588b)5008462-8 |k FZJ |b 1 |6 P:(DE-Juel1)136837 | |
913 | 0 | |a DE-HGF |b Schlüsseltechnologien |l BioSoft: Makromolekulare Systeme und biologische Informationsverarbeitung |1 G:(DE-HGF)POF2-450 |0 G:(DE-HGF)POF2-453 |2 G:(DE-HGF)POF2-400 |v Physics of the Cell |x 0 | |
913 | 1 | |a DE-HGF |b Key Technologies |l BioSoft – Fundamentals for future Technologies in the fields of Soft Matter and Life Sciences |1 G:(DE-HGF)POF3-550 |0 G:(DE-HGF)POF3-553 |2 G:(DE-HGF)POF3-500 |v Physical Basis of Diseases |x 0 |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF3 | |
914 | 1 | |y 2015 | |
915 | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID | ||
915 | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded | ||
915 | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection | ||
915 | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Thomson Reuters Master Journal List | ||
915 | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS | ||
915 | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline | ||
915 | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database | ||
915 | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews | ||
915 | |a DBCoverage |0 StatID:(DE-HGF)1120 |2 StatID |b BIOSIS Reviews Reports And Meetings | ||
915 | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID | ||
980 | |a journal | ||
980 | |a VDB | ||
980 | |a I:(DE-Juel1)ICS-4-20110106 | ||
980 | |a UNRESTRICTED | ||
536 | |a Physical Basis of Diseases |0 G:(DE-HGF)POF3-553 |c POF3-553 |x 0 |f POF III | ||
336 | |a ARTICLE |2 BibTeX | ||
336 | |a Nanopartikel unedler Metalle (Mg0, Al0, Gd0, Sm0) |0 0 |2 EndNote | ||
336 | |a Output Types/Journal article |2 DataCite | ||
336 | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1422884827_13705 |2 PUB:(DE-HGF) | ||
336 | |a article |2 DRIVER | ||
336 | |a JOURNAL_ARTICLE |2 ORCID | ||
981 | |a I:(DE-Juel1)IBI-1-20200312 | ||
920 | |l yes | ||
920 | |k Zelluläre Biophysik; ICS-4 |0 I:(DE-Juel1)ICS-4-20110106 |l Zelluläre Biophysik |x 0 | ||
990 | |a Jensen, Anders A |0 P:(DE-HGF)0 |b 0 |e Corresponding Author | ||
991 | |a Bunch, Lennart |0 P:(DE-HGF)0 |b 3 | ||
991 | |a Bjørn-Yoshimoto, Walden E |0 P:(DE-HGF)0 |b 2 | ||
991 | |a Fahlke, Christoph |0 P:(DE-Juel1)136837 |b 1 |u fzj |